Navigation Links
Abattis Biologix Corporation Begins Trading on Pink Sheets

VANCOUVER, British Columbia, June 17, 2011 /PRNewswire/ -- Abattis Biologix Corporation (CNSX: FLU) announced today that their shares have commenced trading on the OTC Pink Sheets under the symbol ABBTF. Pink Sheet trading will provide shareholders with liquidity as the company proceeds with financing activities and the preparation of additional disclosure documents for listing on higher tier OTC platforms and other exchanges.

Mike Withrow, CEO of Abattis stated, "This is the first in three steps toward becoming a fully reporting issuer with the SEC. The company is fully reporting in Canada and is in the process of converting to IFRS. It will provide transparency about our company in both countries and better access to its stock in the US, which will attract new investors and expand our stockholder base."

"We continue to strengthen our IP and are preparing to launch our portfolio of proprietary products into strategic distribution channels. Shareholders and investors should expect to see additional news releases in the coming weeks on these and other events and activities as we move toward that goal," added Withrow.

About Abattis Biologix Corp.

Abattis Biologix Corporation is committed to the research, development and marketing of proprietary natural health and wellness solutions that address chronic illnesses through targeted nutritional support.  We manufacture and market the most scientifically advanced natural therapeutic formulas based on proprietary technologies through multiple distribution channels, while providing the highest level of customer service.

Web:     Twitter:@abattis

Safe Harbor Statement: This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risk that could cause actual performance and results of operations to differ materially from those anticipated.

Media Contact:
Margie Adelman
916 220 3500

Investor Relations Contact:
Gil Schneider
604 828 8600

SOURCE Abattis Biologix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
2. Theramed Corporation to Launch Glenveigh Products, ebb™ and jetty™ at the Society of Obstetricians and Gynecologists of Canada
3. Mitsubishi Chemical Medience Corporation Receives 510(k) Clearance for PATHFAST® cTnI-II (cardiac Troponin I) Test in U.S.
4. Spectros Corporation Introduces Continuum®, a Broadband Infrared Sensor for Brain and Gut Oximetry
5. AmbiCom Forms Joint Alliance With E-Care Technology Corporation
6. Volcano Corporation Presentation at William Blair Conference to be Webcast
7. President of Minntech Corporation Injured in Plane Crash
8. Translational Sciences Corporation to Launch OncoTrac™ at the American Society of Clinical Oncology (ASCO) Annual Meeting
9. Luminex Corporation to Present at Jefferies 2011 Global Healthcare Conference
10. Volcano Corporation Presentation at Goldman Sachs Conference to be Webcast
11. EMIT Corporation Receives FDA 510(k) Clearance for HypothermX™ Blood and Fluid Warmer.
Post Your Comments:
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... North Carolina , 26 november 2015 ... Inc. (AAIPharma/CML) kondigt de geplande investering aan ... uitbreiding van de laboratoria en het mondiale ... . De uitbreiding zal resulteren in extra ... wordt voldaan aan de groeiende behoeften van ...
(Date:11/26/2015)... 26, 2015 --> ... approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... found that immunotherapy can be efficiently combined with photodynamic ...
Breaking Medicine Technology:
(Date:11/25/2015)... BROOK, Ill. (PRWEB) , ... November 25, 2015 ... ... larger and potentially more aggressive than those found on mammography, according to a ... MRI findings of additional cancers not seen on mammography may necessitate a change ...
(Date:11/25/2015)... ... November 25, 2015 , ... Finnleo, a leader in the traditional and far-infrared ... traditional and far-infrared saunas. , For traditional saunas, Finnleo is offering ... sauna wood, and Finnleo uses only European Grade A Nordic White Spruce from sustainably ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical ... more about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared ... thicker and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... ... ... For the first time, Vitalalert is donating half of its earnings to ... between the two groups began in 2014 with Vitalalert pledging a portion of every ... founded in 1954 and is an international Christian-based health organization whose mission is to ...
(Date:11/25/2015)... ... ... Dental professionals who would like to become more proficient on their knowledge of ... Advanced Implant Mentoring (AIM) CE course. Courses will be held on December 3rd, 4th ... Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud to announce that individuals ...
Breaking Medicine News(10 mins):